Results 241 to 250 of about 185,181 (328)

Drug-Drug Interaction of Warfarin and Doxycycline Leading to a Large Rectus Sheath Hematoma. [PDF]

Cureus
Ansong S, Doad J, Igweonu-Nwakile EO, Okafor C.   +3 more
europepmc   +1 more source

The Holy Grail of cardiology?

Experimental Physiology, EarlyView.
Richard Godfrey
wiley   +1 more source

Predicting right ventricular failure after left ventricular assist device implant: A novel approach

ESC Heart Failure, Volume 12, Issue 3, Page 1916-1931, June 2025.
Abstract Aims Right ventricular (RV) failure (RVF) after left ventricular assist device (LVAD) implant is an important cause of morbidity and mortality. Modern, data‐driven approaches for defining and predicting RVF have been under‐utilized. Methods Two hundred thirty‐two patients were identified with a mean age of 55 years; 40 (17%) were women, 132 ...
Carissa E. Livingston, Dale Kim, Lacey Serletti, Andrea Jin, Sriram Rao, Michael V. Genuardi, Eliot G. Peyster   +6 more
wiley   +1 more source

Demographic and Socio-Economic Disparities in the Outcomes Among Patients with NVAF Treated with Oral Anticoagulants: A Real-World Evaluation of Medicare Beneficiaries. [PDF]

J Clin Med
Atreja N, Dubey A, Kohli M, Jiang J, Hagan M, Aweh G, Adams S, Cheng D.   +7 more
europepmc   +1 more source

Pirtobrutinib in Chinese patients with relapsed or refractory B‐cell malignancies: A single‐arm, open‐label, phase 2, multicenter trial

International Journal of Cancer, Volume 156, Issue 11, Page 2158-2168, 1 June 2025.
What's new? Pirtobrutinib, a highly selective, noncovalent (reversible) Bruton tyrosine kinase inhibitor (BTKi), has shown promise in treating patients with B‐cell malignancies following treatment with covalent BTKis. However, potential geographic and ethnic differences in patient response to pirtobrutinib remain to be clarified.
Yanyan Liu, Ningjing Lin, Shuhua Yi, Huiqiang Huang, Ye Guo, Qingyuan Zhang, Haiyan Yang, Huilai Zhang, Liling Zhang, Ru Feng, Yijiao Qian, Jiankun Zhu, Yuqin Song, Jun Zhu   +13 more
wiley   +1 more source

Venous Thromboembolism Prophylaxis After TKA: Aspirin, Warfarin, Enoxaparin, or Factor Xa Inhibitors?

Clinical Orthopaedics and Related Research, 2017
Abiram Bala, J. Huddleston, S. Goodman, W. Maloney, D. Amanatullah   +4 more
semanticscholar   +1 more source

Continuous use of direct oral anticoagulants during and after simple and surgical tooth extractions: a prospective clinical cohort study. [PDF]

BMC Oral Health
Johansson K, Becktor JP, Naimi-Akbar A, Svensson PJ, Götrick B.   +4 more
europepmc   +1 more source

Investigator‐Initiated Clinical Pharmacokinetic Studies in Resource‐Limited Settings: Minimal Requirements and Practical Guidance

The Journal of Clinical Pharmacology, Volume 65, Issue 6, Page 675-687, June 2025.
Abstract Clinical pharmacology studies are critical for determining the efficacy and safety of drugs. Due to the resource‐intensive nature of these studies, most have been conducted in high‐income countries, leading to a significant gap in clinical pharmacology data for patients in low‐ and middle‐income countries.
Aniek Uittenboogaard, Susan Mageto, Sherif Kamal Eldin Mohamed, Bertrand Pourroy, Benjamin Mwesige, Agness Chisomo Chitedze, Gertjan Kaspers, Festus Njuguna   +7 more
wiley   +1 more source

Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation: An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial

Circulation, 2011
J. Eikelboom, L. Wallentin, Stuart J. Connolly, M. Ezekowitz, Jeff S. Healey, Jonas Oldgren, Sean Yang, M. Alings, Scott Kaatz, S. Hohnloser, Hans-Christoph Diener, M. Franzosi, Kurt Huber, P. Reilly, Jeanne Varrone, Salim Yusuf   +15 more
semanticscholar   +1 more source

Impact of Anemia Management on Bleeding Outcomes in Anticoagulated Patients: A Retrospective Cohort Analysis. [PDF]

Clin Hematol Int
Godin SL, Hanna C, Naut E, Mulay S.
europepmc   +1 more source